traded lower Wednesday after a California appeals court ruled that the company must face claims from thousands of plaintiffs ...

which has become a niche part of the overall HIV market thanks to much-improved oral drug regimens in recent years. In time, Gilead wants in time to extend the use of lenacapavir into additional ...

MIAMI--(BUSINESS WIRE)--AIDS Healthcare Foundation (AHF) advocates ... drug maker continue as Gilead faces legal action over its keeping safer HIV medications off the market to maximize profits.

which could have swapped out an ingredient for a safer alternative. OAKLAND, Calif. (CN) — The biopharmaceutical drug giant Gilead Sciences Inc. must face claims in a federal lawsuit that the company ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...